According to Sanara MedTech's latest financial reports the company has $6.23 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $8.95 M | -51.97% |
2021-12-31 | $18.65 M | 3996.23% |
2020-12-31 | $0.45 M | -93.11% |
2019-12-31 | $6.61 M | 3647.81% |
2018-12-31 | $0.17 M | -61.91% |
2017-12-31 | $0.46 M | -44.43% |
2016-12-31 | $0.83 M | 357.11% |
2015-12-31 | $0.18 M | -65.17% |
2014-12-31 | $0.52 M | 1074.87% |
2013-12-31 | $0.04 M | -2.85% |
2012-12-31 | $0.04 M | 1171.09% |
2011-12-31 | $0 M | -92.9% |
2010-12-31 | $0.05 M | |
2009-12-31 | $N/A | -100% |
2008-12-31 | $0 M | 46.22% |
2007-12-31 | $0 M | -99.67% |
2006-12-31 | $0.23 M | 8255.76% |
2005-12-31 | $0 M | -64.15% |
2004-12-31 | $0 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $95.88 M | 1,437.56% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $25.24 M | 304.82% | ๐บ๐ธ USA |